MPO and Huntington disease: Plasma nucleosome and MPO-DNA levels, an established marker of in vivo NETs, as well as circulating neutrophil counts were significantly higher in HD patients compared to HVs, and they were much higher in HD patients with adverse vascular events compared to those without.